Longevity Acquisition Corp

Completed

Follow

Detailed Information

Information on this SPAC.

Sponsors: Whale Management Corporation
IPO Size: $40M
Underwriters: Cantor Fitzgerald
SEC Filings: 1743858
Public Embarc Page: https://embarc.com/capital/spac/1743858/LOAC/longevity-acquisition
IPO Ticker: LOAC

SPAC Leadership

Information on the SPAC leadership.

Chairman and Chief Executive OfficerMatthew Chen
Chief Financial OfficerTeddy Zheng
DirectorFeng Peng
DirectorJun Liu
DirectorJason Zhang
AdvisorBill Huo

Target Information

Information on the SPAC target for merger.

Company: 4D Pharma
New Ticker: LBPS LBPSW
Description: 4D pharma offers Live Biotherapeutic Products (LBPs), orally delivered single strains of bacteria that are naturally found in the healthy human gut.